MR1 and COVID-19: Along the same line, MAIT cells, which were defined as CD3+ MR1 5-OP-RU tetramer+ (Figure 2C) or CD3+CD161+Vα7.2+ cells (Figure S2A), were significantly reduced in COVID-19 patients compared to healthy controls (Figure 2C).